This book encapsulates recent applications of CI methods in the field of computational oncology, especially cancer diagnosis, prognosis, and its optimized therapeutics.The cancer has been known as a heterogeneous disease categorized in several different subtypes.

Part 1: Preliminaries.- Chapter 1. Computational Intelligence in Oncology: Past, Present, and Future.- Chapter 2. Machine Learning-based Models and their Applications in Diagnosis, Prognosis and Effective Cancer Therapeutics: Current State-of-the-art.- Chapter 3. Computational Intelligent Systems in Oncology: A Way towards Translational Healthcare.- Chapter 4. Computational Resources for Oncology Research: A Comprehensive Analysis.- Part 2: Cancer Detection, Diagnosis, Survival and Recurrence Prediction.- Chapter 5. Application of Convolutional Neural Networks in Cancer Diagnosis.- Chapter 6. Automatic Cancer Detection Using Probabilistic Convergence Theory.- Chapter 7. Computational Intelligence Methods for Cancer Survival Prediction.- Chapter 8. Breast Cancer Survival Prediction Using Machine Learning.- Chapter 9. Deep Learning Models for Classification of Brain Tumor with Magnetic Resonance Imaging Images Dataset.- Chapter 10. Predicting the Cancer Recurrence using Artificial NeuralNetworks.- Chapter 11.  Computer Intelligence in Detection of Malignant or Premalignant Oral Lesions: The Story so far.- Chapter 12. Fuzzy Logic-based Hybrid Models for Clinical Decision Support Systems in Cancer.- Part 3: Predicting Cancer Biomarkers, Therapeutic Targets, Drug Response, and Drug Design, Discovery, and Development.- Chapter 13. Predicting Biomarkers and Therapeutic Targets in Cancer.- Chapter 14. Computational Intelligence: A Step Forward in Cancer Biomarker Discovery and Therapeutic Target Prediction.- Chapter 15. Computational Intelligence Based Cheminformatics Model as Cancer Therapeutics.

This book encapsulates recent applications of CI methods in the field of computational oncology, especially cancer diagnosis, prognosis, and its optimized therapeutics. The cancer has been known as a heterogeneous disease categorized in several different subtypes. According to WHO’s recent report, cancer is a leading cause of death worldwide, accounting for over 10 million deaths in the year 2020. Therefore, its early diagnosis, prognosis, and classification to a subtype have become necessary as it facilitates the subsequent clinical management and therapeutics plan. Computational intelligence (CI) methods, including artificial neural networks (ANNs), fuzzy logic, evolutionary computations, various machine learning and deep learning, and nature-inspired algorithms, have been widely utilized in various aspects of oncology research, viz. diagnosis, prognosis, therapeutics, and optimized clinical management.   Appreciable progress has been made toward the understanding the hallmarks of cancer development, progression, and its effective therapeutics. However, notwithstanding the extrinsic and intrinsic factors which lead to drastic increment in incidence cases, the detection, diagnosis, prognosis, and therapeutics remain an apex challenge for the medical fraternity. With the advent in CI-based approaches, including nature-inspired techniques, and availability of clinical data from various high-throughput experiments, medical consultants, researchers, and oncologists have seen a hope to devise and employ CI in various aspects of oncology. The main aim of the book is to occupy state-of-the-art applications of CI methods which have been derived from core computer sciences to back medical oncology. This edited book covers artificial neural networks, fuzzy logic and fuzzy inference systems, evolutionary algorithms, various nature-inspired algorithms, and hybrid intelligent systems which are widely appreciated for the diagnosis, prognosis, andoptimization of therapeutics of various cancers. Besides, this book also covers multi-omics exploration, gene expression analysis, gene signature identification of cancers, genomic characterization of tumors, anti-cancer drug design and discovery, drug response prediction by means of CI, and applications of IoT, IoMT, and blockchain technology in cancer research.

Covers exclusive applications of computational intelligence Presents cancer recurrence prediction, survival prediction, and detection of malignant or premalignant lesions Includes fundamental concepts of computational oncology, translational health care, and gene expression analysis

GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com